Fig. 4
From: Integrated analysis of droxidopa trials for neurogenic orthostatic hypotension
Mean score change* from baseline to week 1/EOS: (a) OHQ, (b) OHSA, and (c) OHDAS. EOS = end of study; OHDAS = Orthostatic Hypotension Daily Activity Scale; OHQ = Orthostatic Hypotension Questionnaire; OHSA = Orthostatic Hypotension Symptom Assessment. *Score change on a rating scale from 0 (none/no interference) to 10 (worst possible/complete interference). A negative change represents a decrease in symptom burden